Retail pharmacy heavyweight CVS Caremark has added a drug interaction checker to its CVS Mobile app that cautions consumers when an over-the-counter medication might interact with other drugs they are taking. The Woonsocket, RI-based company says it is the first drugstore chain to include such a feature in a mobile app.
With the new interaction checker, users can scan the barcodes on OTC...
It turned out to be an eventful second quarter. While the first three months of 2013 were peppered with notable launches, acquisitions, and shutdowns – for the first half of Q2 not much news was shaking in digital health.
In recent weeks health plans and providers launched important data sharing initiatives; a high-profile mobile health company secured reimbursement and – perhaps more importantly...
Ayogo's Diabestes app for college students.
Health gaming company Ayogo's CEO Michael Fergusson hinted at this week's Games for Health event in Boston that the company is working on a new game for a major pharmaceutical company, although he wasn't able to reveal any details.
"I sure would like to show you this game but I didn't get clearance to show it. We're working with one of the five largest...
Pharmaceutical giant Novartis has tapped intelligent medicine start-up Proteus Biomedical for a small 20 patient study to track patients' compliance with their blood pressure drug regimen. The patients are taking blood pressure drug Diovan and the study organizers track their compliance via Proteus' "chip in the pill" technology, which reports to a receiver sensor on the patient's shoulder when...
A new report conducted by the New England Healthcare Institute (NEHI) found that not taking medications as prescribed leads to poorer health, more frequent hospitalization, a higher risk of death and as much as $290 billion annually in increased medical costs. Anywhere from one-third to one-half of patients in the U.S. do not take their medications as instructed. Not taking the medication on time...
MYLEstone Health, developer of the Glucose Buddy iPhone app, is working with Roche Diagnostics' Accu-Chek to add its educational program to the Glucose Buddy diabetes management app. Even though the addition of Accu-Chek's educational program to the iPhone app is a far cry from meter integration, MYLEstone co-founder Matthew Tendler told mobihealthnews, it is a step in the right direction and it...
Proteus Biomedical CEO Andrew Thompson describes his company as a pioneer of intelligent medicine -- Proteus embeds computers and sensors inside drugs and devices to monitor in real-time when a patient takes a drug and how they respond to it. Thompson says the service will also include reminders and notices for patients' caregivers or family members to keep them in the loop. And although Thomspon...
You've probably seen it on TV, but it's not common practice: The patient is immersed in an ice water bath to lower body temperature and draw out symptoms -- to determine what the real issues are. After three weeks on the road at various tech conferences, the mobihealthnews team feels like some speakers at The World Health Care Congress in Washington D.C. gave us the ice water bath treatment. And...
Novartis CEO and Chairman Daniel Vasella said that technology solutions do not do an adequate job of solving the medical adherence and compliance problem that faces the healthcare and pharmaceutical industries.
Internet programs that provide feedback loops to patients, instruments that can measure biometrics and transmit the data to caregivers, and new pill bottles that can remind you (by text...
According to a report from Signs of the Times, "two major drugs companies" in the UK are set to begin clinical trials of Proteus Biomedical's wireless pill technology, Raisin. Trials will reportedly commence within the next 12 months.
Imperial College London cardiologist and professor Nick Peters will coordinate the trials.
"This is all about empowering patients and their families because it...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
